Digital transformation continues to play out across various corners of the healthcare world, and the cardiovascular space is no different. Heart disease remains one of the deadliest and costliest ...
NEWPORT BEACH, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- via InvestorWire -- Octane, an innovative organization building the SoCal of Tomorrow by connecting people, resources, and capital to fuel ...
In a large multi-ethnic group of adults in the United States without cardiovascular disease, those with work-related stress were more likely to have unfavorable measures of cardiovascular health. The ...
In a large multi-ethnic group of adults in the United States without cardiovascular disease, those with work-related stress were more likely to have unfavorable measures of cardiovascular health. The ...
The 2025 Lubbock Heart Walk, the signature event of the American Heart Association, will return to the Texas Tech campus on ...
The planned acquisition of V-Wave will extend Johnson & Johnson MedTech's position in addressing cardiovascular disease. The FDA also approved Rybrevant (amivantamab) plus Lazcluze (lazertinib) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback